BridgeMD
New treatment option for Osseointegration
Official title Erythropoietin Gel Effect on Dental Implant Stability
ClinicalTrials.gov ID: NCT06665451
What this study is testing
- What it's testing
- Achieving and maintaining long-term osseointegration for dental implants is a key objective in the field of dentistry. The success of osseointegration is influenced by the surface treatment applied to dental implants.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50. Healthy volunteers may be eligible.
You may be able to join if
- All patients Should have nonrestorable teeth in the anterior maxilla indicated for extraction and seeking implant placement.
- Good general periodontal health and maintenance.
You likely can't join if
- Heavy smokers who smoke more than ten cigarettes per day
- Acute infected socket
- Ant socket with wall defect.
- Pregnency
- Local or systemic conditions that will interfere with bone healing (uncontrolled diabetes mellitus or human immune deficiency virus infections...
- Patients who had subjected to intravenous and/or oral bisphosphonate therapy.
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Asyut Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Asyut Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.